TDCS-RTMS Intervention for Motor Function

Inclusion Criteria: * The patients were 18-70 years old, clinically diagnosed as classic or incomplete atresia syndrome, and the onset time was 6 weeks-1 year. * Clear consciousness, effective communication and command response through eye movement or other established methods. * No drugs (sodium, calcium channel blockers or sedatives) that may affect neuromuscular function or brain stimulation effect were used, or the drugs were stably stopped for more than 1 week before enrollment. * The patient or his legal guardian signed the informed consent form and agreed to cooperate in completing all test procedures and evaluations. Exclusion Criteria: * Metal implants (such as cardiac pacemaker, intracranial metal clip, etc.), electronic equipment or other TMS contraindications. * Complicated with severe cognitive impairment (such as dementia) or unable to cooperate to complete the assessment scale test. * Have a history of severe cardiopulmonary dysfunction, mental illness and seizures. * There are other neurodegenerative diseases that affect the recovery of motor function (such as amyotrophic lateral sclerosis, etc.) * Recently (within 1 month) participated in other clinical trials related to neuromodulation therapy.